Brief: Exopharm Promotes Chris Baldwin As Deputy CEO In Addition To CCO Role
April 8 (Reuters) - Exopharm Ltd EX1.AX :
* PROMOTES CHRIS BALDWIN AS DEPUTY CEO IN ADDITION TO CCO
ROLE
Source text for Eikon: ID:nASX2NRXmK
Further company coverage: EX1.AX
((reuters.briefs@thomsonreuters.com))
Recent news on Entropy Neurodynamics
See all newsBrief: Entropy Neurodynamics Seeks Trading Halt
Brief: Entropy Neurodynamics Says Strategic Agreement Signed With CDMO Biocina
Brief: Entropy Neurodynamics Secures HREC Approval For Phase 1B/2A 8-Indication Basket Study Of TRP-8803
Brief: Entropy Neurodynamics Requests Trading Halt
Brief: Entropy Neurodynamics Seeks Trading Halt